Introduction
The high incidence of back pain, its chronic and recurrent nature in many patients, and its contribution as a main cause of absence from work are well known. No general consensus exists about the most effective treatment. Largely anecdotally, patients and therapists often claim great improvements after manipulative treatment by alternative practitioners, including chiropractors. A recent report from the board of science and education of the BMA considered that manipulative treatment ofback pain by lay practitioners may provide "a safe and helpful service,"' thus strengthening the Cochrane committee's recommendation that randomised trials of treatment for back pain should include an evaluation of heterodox methods.
A comparison of chiropractic with conventional hospital outpatient management of low back pain could take one of two main forms. Firstly, it could be a "pragmatic" trial, which would test what happens in day to day practice and in which details of the type, frequency, and duration of treatment would be at the discretion of the chiropractor or hospital team.' The disadvantage of a pragmatic trial is that if a clear difference is found between the treatments it may not be possible to identify the components of the more successful treatment that were responsible. Secondly, it could be a "fastidious" trial, which would compare chiropractic manipulation with a particular form of non-manipulative physiotherapy.' Though this type of trial may be more likely to identify specific components of treatment that are effective, there would be a high chance of not including the effective components because of the many techniques used to treat back pain.4 In addition, its results might have only limited applicability.
We adopted a pragmatic approach for two main reasons: firstly, because of the probable difficulty of securing agreement about standard forms of treatment, particularly in hospital, and consequently the small number of patients who could be recruited into a fastidious trial and, secondly, because the effectiveness oftreatment in day to day practice, whether chiropractic or in hospital, is of most immediate interest to patients as well as doctors and therapists.
Patients and methods

CENTRES AND CLINICS
The study was based on the methods of a feasibility study.4 Each centre consisted of a chiropractic clinic and a hospital clinic. After the feasibility studv had been completed 11 centres with hospital and chiropractic clinics within a reasonable distance of one another agreed to take part in this trial. The main criterion for eligibility was that patients should have no contraindication to manipulation as almost all the patients treated by chiropractic would receive manipulation and it was important to avoid damage by manipulation. Thus patients were excluded if there was evidence that a nerve root was affected, though restricted straight leg raising on its own was not a reason for exclusion; major structural abnormalities were visible on radiography; or osteopenia or an infectious cause was suspected and for various other reasons, including social conditions and pending litigation. Only patients aged 18 to 65 who had not been treated within the past month and who had not attended the same referral clinic within the past two years were recruited.
Two of the 11 centres kept a record of all patients presenting with back pain. 
STATISTICS
We recruited as many patients as the available funding allowed. We estimated from the feasibility study that about 2000 patients would be needed to detect a difference between the two approaches of 2% points on the Oswestry scale (at the 5% level, with 90% power)-for example, a decrease in Oswestry score from 30% to 25% in one group compared with a decrease from 30% to 23% in the other-and that differences of 2-5%, 3 0%, 4 0% and 5 0% points would require about 1200, 850, 500, and 300 patients respectively. Table II absence of a history of back pain, and an Oswestry score at entry of >40% or -40%. The feasibility study had shown that the length of the current episode, in particular, clearly distinguished two groups of patients, those with a short current episode improving much more rapidly (regardless of treatment) than those with longer episodes.
The interval between recruitment and the start of treatment varied slightly among the four referral and treatment clinic groups. To allow for any changes before the start of treatment the results were based on changes in Oswestry scores, and this also allowed for the small differences in pretreatment scores between the hospital and chiropractic groups (see table III ). tp<0o000l.
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Discussion
Though many randomised controlled trials of treatments for back pain have been carried out, there have so far been no clear indications in favour of any particular method. The place of manipulation in back pain has been reviewed by Jayson," who concluded that any minor benefits seemed to be confined to those with acute pain of recent onset, that there was no evidence that manipulation helped those with severe or chronic back problems, and that it did not reduce long BMJ VOLUME 300 2 JUNE 1990 *p<0-05, **p-o.0l, ***p-OOl.
period than other trials comparing orthodox treatments or, less often, orthodox and alternative treatments.
We studied only patients who had no contraindications to manipulation. Although this group represents a substantial proportion of all patients with back pain, the findings cannot be automatically applied to all patients with back pain. With this proviso the results leave little doubt that chiropractic is more effective than conventional hospital outpatient treatment. The confidence intervals for the differences in Oswestry scores were wide, but the degree of improvement recorded for many of the secondary outcome measures (table VI) suggests that chiropractic has appreciable benefit. The effects of chiropractic seem to be long term, as there was no consistent evidence of a return to pretreatment Oswestry scores during the two years of follow up, whereas those treated in hospital may have begun to deteriorate after six months or a year. Chiropractic was particularly effective in those with fairly intractable pain-that is, those with a history and severe pain. Although we have discussed the results in terms of differences at the various follow up intervals, the full effects of treatment are better thought of as an integrated benefit throughout the two year follow up period, represented by the area between the curves for the two treatments. The greater proportions ofpatients treated by chiropractic who were satisfied and relieved at six weeks, when 90% ofpatients had provided follow up data, strengthens the likelihood that the differences in Oswestry scores and other variables later on, when fewer patients have provided data, were true differences.
The results from the secondary outcome measures ( The fact that chiropractic treatment tended to be more effective in those initially presenting to the chiropractors than in those presenting to hospital raises the possibility that the self assessment by the patients who presented to chiropractors may have been influenced by their expectation that chiropractic would be effective. The results in all patients who had been followed up for two years, however, indicate a similar effect of chiropractic in both referral groups (table V) . There were several differences between the two referral groups that may have influenced response to treatment (these will be reported in detail elsewhere). For example, a significantly higher proportion of patients initially attending the chiropractors had had previous episodes of back pain. Those initially attending chiropractors had also waited much less time for appointments for the current episode and scored significantly less on questionnaires for depressive and inappropriate symptoms and for somatic awareness than the patients initially attending hospital. In addition, the analyses among the (non-clinic) subgroups prespecified in the minimisation procedure were balanced for referral clinic, there being similar proportions initially presenting to chiropractors and to hospital in each of the randomised treatment groups. Yet the tendency for chiropractic to be more effective was not universalfor example, the absence of clear benefit in those with no previous history of back pain. Finally, the self exclusion of many patients who initially presented to the chiropractors probably resulted in only a few of these patients who might automatically have assessed themselves as better after chiropractic or worse after hospital treatment being included. In summary, it is unlikely that the benefits of chiropractic are the result of biased outcome assessments or of a placebo effect.
Centres where chiropractic was more effective at six weeks and six months and those where there was less difference between the two treatments at that stage contributed to the results to about the same extent at a year and two years. The sustained effect ofchiropractic was therefore probably not due to a disproportionate contribution from individual centres where there was an obvious early benefit from chiropractic.
In ADDENDUM-In view of the long term benefit apparently due to chiropractic we initiated a three year follow up, sending multiple reminders to those initially not responding. By mid April 1990-beyond the closing date for the earlier results -data were available for 113 patients, representing a 79% response. At three years the mean fall in Oswestry score for those treated by chiropractic was 9-6% points more than for those treated in hospital (p=0-01). The fall was greater (13 8% p=0 0003) among those presenting with current episodes of more than a month's duration than for those presenting with episodes of less than a month (5 3%, NS). Among those with a previous history of back pain, the improvement in Oswestry score at three years was 9-7% points greater in patients treated by chiropractic than those treated in hospital (p=002). A similar difference between the two forms of treatment (9-4%) was found among those with no previous history of back pain, but numbers in this group were smaller and the difference was not significant. Twenty seven patients in hospital who were confined to bed were given low molecular weight heparin, either Fraxiparine (3300 anti-factor X a units daily) or enoxaparin (2100 units daily), to prevent thromboembolic complications. The treatment was stopped when the patients could get up. The doses were available prepackaged in subcutaneous injection syringes and designed to prevent venous thrombosis. Patients who had diabetes mellitus or renal insufficiency, or were taking drugs known to interfere with aldosterone metabolism (converting enzyme inhibitors or antialdosterone drugs) were not included. Two patients continued taking frusemide (20 mg/day) during the study; none of the other patients took diuretics. All patients received the standard hospital diet (normal salt intake) throughout the study.
Blood samples were taken before treatment, after four days of treatment, and three days after treatment had been stopped. Blood was taken in the morning after at least 12 hours' supine rest. It was analysed for serum sodium and potassium concentrations with an automatic analyser (Technicon, Dublin, Ireland), and plasma aldosterone and cortisol concentrations and renin activity with a radioimmunoassay. (The plasma samples were kept at -20°C until the end of the analysis, and each patient's plasma was assayed for all three periods simultaneously to eliminate interassay variations.)
Results
Twelve patients received enoxaparin (seven women, five men; mean (SD) age 68-3 (11 7) years (range 37-79)), and 15 received Fraxiparine (11 women, four men; mean age 70 3 (13-0) years (range 34-85)). The plasma aldosterone concentration had decreased after four days of treatment by a mean of 43-9 (4 11)% (p<0-001). Three days after the treatment was stopped the concentration had almost returned to initial values (table) . No difference was found between patients receiving enoxaparin and Fraxiparine. The two patients taking frusemide, who initially had high plasma aldosterone concentrations also had decreased plasma aldosterone concentrations during treatment with low molecular weight heparin. In four patients (three taking enoxaparin, one Fraxiparine) plasma aldosterone was not detectable during treatment.
The mean serum potassium concentration increased significantly (p<0001) during treatment with both drugs and decreased after treatment was stopped. The other variables measured did not change significantly.
Comment
We found that low molecular weight heparin inhibited the production of aldosterone, as does standard heparin. The mechanism whereby heparin inhibits aldosterone biosynthesis is not proved. Several Mean (SD) values of biochemical variables measured in elderl, patients before, durlng (after four days' treatment), and (three days) after treatment with low molecular weight heparins 
